Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TürkçeRevvity (RVTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Revvity (RVTY) reported $772.06 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 5.9%. EPS of $1.70 for the same period compares to $1.42 a year ago.
The reported revenue represents a surprise of +0.02% over the Zacks Consensus Estimate of $771.9 million. With the consensus EPS estimate being $1.63, the EPS surprise was +4.29%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Revvity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Organic revenue growth - Total: 4% versus the five-analyst average estimate of 2.4%. Organic revenue growth - Life Sciences: 0% versus 1% estimated by three analysts on average. Organic revenue growth - Diagnostics: 7% versus the three-analyst average estimate of 3.6%. Net Sales- Life Sciences: $381.99 million compared to the $376.21 million average estimate based on four analysts. The reported number represents a change of +13.6% year over year. Net Sales- Diagnostics: $390.07 million versus $385.54 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -0.8% change.View all Key Company Metrics for Revvity here>>>
Shares of Revvity have returned +10.9% over the past month versus the Zacks S&P 500 composite's +0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Revvity Inc. (RVTY): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).